Publication | Open Access

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Bone DiseaseDenosumab TreatmentBone HealthPhase 3OsteopathyFreedom TrialClinical TrialsGynecologyMenopauseMedicineOsteoporosisWomen's Health